dc.contributor.author | Godman, Brian | |
dc.contributor.author | Egwuenu, Abiodun | |
dc.contributor.author | Ncube, Nondumiso B. Q. | |
dc.date.accessioned | 2022-09-13T10:40:08Z | |
dc.date.available | 2022-09-13T10:40:08Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Godman, B. et al. (2022). Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future. Expert Opinion on Drug Safety, 21(8), 1089-1111. 10.1080/14740338.2022.2106368 | en_US |
dc.identifier.issn | 1744-764X | |
dc.identifier.uri | https://doi.org/10.1080/14740338.2022.2106368 | |
dc.identifier.uri | http://hdl.handle.net/10566/7878 | |
dc.description.abstract | Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns with rising AMR have resulted in international, Pan-African, and country activities including the development of national action plans (NAPs). However, there is variable implementation across Africa with key challenges persisting. Areas covered: Consequently, there is an urgent need to document current NAP activities and challenges across sub-Saharan Africa to provide future guidance. This builds on a narrative review of the literature. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis Group | en_US |
dc.subject | Antimicrobial resistance | en_US |
dc.subject | National action plan | en_US |
dc.subject | Public health | en_US |
dc.subject | Mortality | en_US |
dc.subject | Sub-Saharan Africa | en_US |
dc.title | Tackling antimicrobial resistance across Sub-Saharan Africa: Current challenges and implications for the future | en_US |
dc.type | Article | en_US |